Enzon Pharmaceuticals, Inc. (ENZN) Swings to Q1 Loss

Article Stock Quotes (1) Comments (0)

Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) reported Q1 EPS of ($0.02), versus $0.01 reported last year. Revenue for the quarter came in at $10.6 million, versus $18.02 million reported last year.

For earnings history and earnings-related data on Enzon Pharmaceuticals, Inc. (ENZN) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
• UPDATE: Sears Holding Corp. (SHLD) Reports Q1 Loss of $1.29
• Taomee Holdings Ltd. (TAOM) Misses Q1 EPS by 2c; Guides Q2 Sales

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?